Source: Accesswire

Press Release: RHO : Rho to Lead U.S. Clinical Trials for Next Generation of COVID-19 Vaccines as Part of $5 Billion NextGen Initiative

Read full article »

RHO's Competitors | RHO's News | RHO's Financials

Followers on Owler

695

Est. Annual Revenue

$25-100M

Est. Employees

250-500

Laura Helms Reece's photo - CEO of RHO

CEO

Laura Helms Reece

CEO Approval Rating

68/100

Rho is a contract research organization with expertise, integrity, and passion for clinical research.